Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain
The findings represent the first step to potentially augmenting current risk models with Lp(a) measurements, the author says.
The findings represent the first step to potentially augmenting current risk models with Lp(a) measurements, the author says.
Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes…
Join us in this episode as Trudie Lobban, Founder and Trustee of Arrhythmia Alliance, discusses the remarkable work of Pace4Life. This innovative charity
The two-tiered classification focuses on preclinical and clinical stages of disease, and should help inform treatment decisions.
With your help, ACC Advocacy actively works with Congress, state legislators, and other key decision makers to transform cardiovascular care and improve heart health. However,…
The peaceful succession of presidents is sacrosanct in American democracy and marks the United States as an “exceptional nation” which does not experience the same…
Many cancer decedents in the United States had an implantable cardioverter defibrillator (ICD), and those with ICDs received more aggressive care at the end of…
Clyde Yancy, MD, spoke with Cardiovascular Business about how the treatment of heart failure with preserved ejection fraction (HFpEF) has evolved in recent years.
In this month’s issue of The Annals, Wisniewski and associates1 have reported on the results of an observational study investigating the association between the timing…
The Investor Relations website contains information about Verve Therapeutics’s business for stockholders, potential investors, and financial analysts.